[1] Moreira, A.L.R, Van Meter, A, Genzlinger, J. & Youngstrom, E.A. Review and meta-analysis of epidemiologic studies of adult bipolar disorder. J. Clin. Psychiatry. 78, 1259–1269. https://doi:10.4088/JCP.16r11165 (2017)
[2] Szepesi, Z, Manouchehrian, O, Bachiller, S. & Deierborg, T. Bidirectional microglia-neuron communication in health and disease. Front. Cell. Neurosci. 12, 323. https://doi:10.3389/fncel.2018.00323 (2018)
[3] Borges, S.Q, Corrêa, T.X, Trindade, I.O.A, Amorim, R.F.B. & Toledo, M.A.V. Cognitive impairment in bipolar disorder Neuroprogression or behavioral variant frontotemporal dementia? Dement.Neuropsychol. 13, 475–480. https://10.1590/1980-57642018dn13-040016 (2019)
[4] Berk, M. Neuroprogression: pathways to progressive brain changes in bipolar disorder. International Journal of Neuropsychopharmacology. 12(4), 441-445.https://doi.org/10.1017/S1461145708009498 (2009)
[5] Grande, I, Magalhães, P.V, Kunz, M, Vieta, E. & Kapczinski, F. Mediators of allostasis and systemic toxicity in bipolar disorder. Physiology & behavior. 106(1), 46-50. https://doi.org/10.1016/j.physbeh.2011.10.029 (2012)
[6] Sylvia, L.G. et al. Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE). Bipolar disorders. 17(2), 212-223. https://doi.org/10.1111/bdi.12243 (2015)
[7] Kapczinski, F. et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neuroscience & Biobehavioral Reviews. 32(4), 675-692. https://doi.org/10.1016/j.neubiorev.2007.10.005 (2008)
[8] Goldstein, S, Naglieri, J.A, Princiotta, D. & Otero, TM. A history of executive functioning as a theoretical and clinical construct. Handbook of Executive Functioning. New York: Springer New York. https://doi.org/10.1007/978-1-4614-8106-5_1 (2014)
[9] Collin, F. Chemical basis of reactive oxygen species reactivity and involvement in neurodegenerative diseases. Int. J. Mol. Sci. 20, 2407. https://doi:10.3390/ijms20102407 (2019)
[10] Cyrino, L.A.R, Delwing-de Lima, D, Ullmann, O.M. & Maia, T.P. Concepts of Neuroinflammation and Their Relationship with Impaired Mitochondrial Functions in Bipolar Disorder. Frontiers in Behavioral Neuroscience. 15. https://doi:10.3389/fnbeh.2021.609487 (2021)
[11] Young, R.C, Biggs, J.T, Ziegler, V.E. & Meyer, D.A. A rating scale for mania: reliability, validity and sensitivity. The British journal of psychiatry. 133(5), 429- 435. https://doi:10.1192/bjp.133.5.429 (1978)
[12] Hamilton, M.A. rating scale for depression. Journal of neurology, neurosurgery, and psychiatry. 23(1), 56. https://doi.org/10.1136 / jnnp.23.1.56 (1960)
[13] Rosa, A.R. et al. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clinical Practice and Epidemiology in Mental Health. 3(1), 1-8. https://doi:10.1186/1745-0179-3-5 (2007)
[14] Bonnín, C.M. et al. Thresholds for severity, remission and recovery using the functioning assessment short test (FAST) in bipolar disorder. Journal of affective disorders. 240, 57-62. https://doi:10.1016 / j.jad.2018.07.045 (2018)
[15] Dubois, B, Slachevsky, A, Litvan, I. & Pillon, B. The FAB: a frontal assessment battery at bedside. Neurology. 55(11), 1621-1626. (https://doi.org/10.1212 / wnl.55.11.1621 (2000)
[16] Lima, C.F, Meireles, L.P, Fonseca, R, Castro, S.L. & Garrett, C. The Frontal Assessment Battery (FAB) in Parkinson’s disease and correlations with formal measures of executive functioning. Journal of neurology. 255(11), 1756-1761. https://doi.org/10.1007 / s00415-008-0024-6 (2008)
[17] Caixeta, L. et al. Executive function is selectively impaired in old age bipolar depression. Frontiers in psychology. 8, 194. https://doi.org/10.3389/fpsyg.2017.00194 (2017)
[18] Gowda, S.N, Chandak, S, Sawant, V. & Kulkarni, A. Comparison of neurocognitive deficits among euthymic bipolar I disorder patients, their first degree relatives and healthy controls. Int J Adv Med. 4(3), 656-660. http://dx.doi.org/10.18203/2349-3933.ijam20171513 (2017)
[19] Zhang, Y. et al. Psychometric properties of the Chinese version of the Functioning Assessment Short Test (FAST) in bipolar disorder. Journal of affective disorders. 238, 156-160. https://doi:10.1016/j.jad.2018.05.019 (2018)
[20] Orhan, M. et al. Reliability and validity of the functioning assessment short test for older adults with bipolar disorder (FAST-O). International Journal of Bipolar Disorders. 8(1), 1-7. https://doi.org/10.1186/s40345-020-00193-2 (2020)
[21] Ohkawa, H, Ohishi, N. & Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical biochemistry. 95(2), 351-358.https://doi.org/10.1016/0003-2697(79)90738-3 (1979)
[22] Marklund, S.L. Product of extracellular‐superoxide dismutase catalysis. FEBS letters. 184(2), 237-239. https://doi.org/10.1016/0014-5793(85)80613-X (1985)
[23] Aebi, H. Catalase in vitro. Methods in enzymology. 105, 121-126. https://doi.org/10.1016/S0076-6879(84)05016-3 (1984)
[24] Wendel, A. Glutathione peroxidase. In methods in enzymology 77, 325-333. Academic Press https://doi.org/10.1016/S0076-6879(81)77046-0 (1981)
[25] Tunçel, ÖK. et al. Oxidative stress in bipolar and schizophrenia patients. Psychiatry research. 228(3), 688-694. https://doi.org/10.1016/j.psychres.2015.04.046 (2015)
[26] Siwek, M. et al. Thiobarbituric acid-reactive substances: markers of an acute episode and a late stage of bipolar disorder. Neuropsychobiology. 73(2), 116-122. https://doi.org/10.1159/000444491 (2016)
[27] Valvassori, S.S. et al. Increased oxidative stress in the mitochondria isolated from lymphocytes of bipolar disorder patients during depressive episodes. Psychiatry research. 264, 192-201. https://doi.org/10.1016/j.psychres.2018.03.089 (2018)
[28] Ifeanyi, O.E. A review on free radicals and antioxidants. Int. J. Curr. Res. Med. Sci. 4(2), 123-133. http://dx.doi.org/10.22192/ijcrms.2018.04.02.019 (2018)
[29] Moniczewski, A. et al. Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 1. Chemical aspects and biological sources of oxidative stress in the brain. Pharmacological Reports. 67(3), 560-568. https://doi.org/10.1016/j.pharep.2014.12.014 (2015)
[30] Ghezzi, D. and Zeviani, M. Assembly factors of human mitochondrial respiratory chain complexes: physiology and pathophysiology. Adv. Exp. Med. Biol. 748, 65–106. https://doi:10.1007/978-1-4614-3573-0_4 (2012)
[31] Kurutas, E.B. The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state. Nutr. J. 15; 71. https://doi:10.1186/s12937-016-0186-5 (2016)
[32] Espinosa-Diez, C. et al. Antioxidant responses and cellular adjustments to oxidative stress. Redox Biol. 6, 183–197. https://doi:10.1016/j.redox.2015.07.008 (2015)
[33] Machado-Vieira, R. et al. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neuroscience letters. 421(1), 33-36. https://doi:10.1016/j.neulet.2007.05.016 (2007)
[34] Andreazza, A.C. et al. 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. Journal of psychiatry & neuroscience: JPN. 34(4), 263. http://jpn.ca/wpcontent/uploads/2014/04/34-4-263.pdf. (2009)
[35] Pfaffenseller, B. et al. Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder. Expert Rev. Neurother. 13, 827–842. https://doi:10.1586/14737175.2013.811981 (2013)
[36] Young, A.H. & Juruena, MF. (eds) Bipolar Disorder: From Neuroscience to Treatment. Current Topics in Behavioral Neurosciences. 48. Springer, Cham. https://doi.org/10.1007/7854_2020_179 (2020)
[37] Jiménez‐Fernández, S. et al. Oxidative stress parameters and antioxidants in patients with bipolar disorder: Results from a meta‐analysis comparing patients, including stratification by polarity and euthymic status, with healthy controls. Bipolar Disorders. 23(2), 117-129. https://doi.org/10.1111/bdi.12980 (2021)
[38] Andreazza, A.C. et al. Oxidative stress markers in bipolar disorder: a meta-analysis. Journal of affective disorders. 111(2-3), 135-144. https://doi.org/10.1016/j.jad.2008.04.013 (2008)
[39] Brown, N.C, Andreazza, A.C. & Young, L.T. An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatry Research, 218(1-2), 61-68. https://doi.org/10.1016/j.psychres.2014.04.005 (2014)
[40] Rowland, T. et al. Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses. Br. J. Psychiatry. 213, 514–525. https://doi:10.1192/bjp.2018.144 (2018)
[41] Selek, S, Altindag, A, Saracoglu, G. & Aksoy, N. Oxidative markers of myeloperoxidase and catalase and their diagnostic performance in bipolar disorder. Journal of affective disorders. 181, 92-95. https://doi.org/10.1016/j.jad.2015.03.058 (2015)
[42] Solanki, N, Salvi, A, Patki, G. & Salim, S. A modulação do estresse oxidativo alivia as deficiências comportamentais e cognitivas induzidas pelo estresse em ratos. The international journal of neuropsychopharmacology. 20(7), 550–561. https://doi.org/10.1093/ijnp/pyx017 (2017)
[43] Mwangi, B. et al. Individualized prediction and clinical staging of bipolar disorders using neuroanatomical biomarkers. Biological psychiatry: cognitive neuroscience and neuroimaging. 1(2), 186-194 https://doi.org/10.1016/j.bpsc.2016.01.001 (2016)
[44] Hurtado‐Pomares, M. et al. The frontal assessment battery in clinical practice: a systematic review. International journal of geriatric psychiatry. 33(2), 237-251. https://doi.org/10.1002/gps.4751 (2018)
[45] Szmulewicz, A, Valerio, M.P. & Martino, D.J. Longitudinal analysis of cognitive performances in recent‐onset and late‐life Bipolar Disorder: A systematic review and meta‐analysis. Bipolar disorders. 22(1), 28-37. https://doi.org/10.1111/bdi.12841 (2020)
[46] Yang, T. et al. Exploring the Effects of Temperament on Gray Matter Volume of Frontal Cortex in Patients with Mood Disorders. Neuropsychiatric Disease and Treatment. 17, 183. https://doi.org/10.2147/NDT.S287351 (2021)
[47] Lewandowski, K.E, Cohen, B.M, Keshavan, M.S, Sperry, S.H. & Öngür, D. Neuropsychological functioning predicts community outcomes in affective and non-affective psychoses: a 6-month follow-up. Schizophrenia research. 148(1-3), 34-37. https://doi.org/10.1016 / j.schres.2013.05.012 (2013)
[48] Gitlin, M.J, Swendsen, J, Heller, T.L. & Hammen, C. Relapse and impairment in bipolar disorder. The American journal of psychiatry. https://doi.org/10.1176/ajp.152.11.1635 (1995)
[49] Keck Jr, P.E. et al. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. American Journal of Psychiatry. 155(5), 646-652. https://doi.org/10.1176/ajp.155.5.646 (1998)
[50] Wang, T.L, Hung, Y.H. & Yang, C.C. Psychometric properties of the Taiwanese (traditional Chinese) version of the Frontal Assessment Battery: A preliminary study. Applied Neuropsychology: Adult. 23(1), 11-20. https://doi:org/10.1080/23279095.2014.995792 (2016)
[51] Tohen, M. et al. The McLean-Harvard first-episode mania study: prediction of recovery and first recurrence. American Journal of Psychiatry. 160(12), 2099-2107. https://doi:10.1176/appi.ajp.160.12.2099. (2003)
[52] Fritz, K. et al. Is a delay in the diagnosis of bipolar disorder inevitable? Bipolar disorders. 19(5), 396-400 (2017). https://doi.org/10.1111/bdi.12499
[53] Strakowski, S.M, Williams, J.R, Fleck, D.E. & Delbello, M.P. Eight-month functional outcome from mania following a first psychiatric hospitalization. Journal of Psychiatric Research. 34(3), 193-200 (2000). https://doi.org/10.1016/S0022-3956(00)00015-7